The store will not work correctly when cookies are disabled.
(5-Acetamido-2-oxindole-3-yl)aceticacid
ID: ALA4077548
PubChem CID: 137651217
Max Phase: Preclinical
Molecular Formula: C12H12N2O4
Molecular Weight: 248.24
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(=O)Nc1ccc2c(c1)C(CC(=O)O)C(=O)N2
Standard InChI: InChI=1S/C12H12N2O4/c1-6(15)13-7-2-3-10-8(4-7)9(5-11(16)17)12(18)14-10/h2-4,9H,5H2,1H3,(H,13,15)(H,14,18)(H,16,17)
Standard InChI Key: QTPWUYQQXFCEQI-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 19 0 0 0 0 0 0 0 0999 V2000
14.2282 -9.0503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4298 -9.2210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8066 -9.6286 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.4829 -8.2730 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.1752 -11.3206 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.6594 -10.6574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4766 -10.6574 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.1752 -9.9982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4021 -10.2488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6930 -9.8402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9839 -10.2488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9839 -11.0660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6930 -11.4746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4021 -11.0660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5698 -10.2488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8607 -9.8402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5698 -11.0660 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.2748 -9.8402 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 2 0
1 4 1 0
5 6 1 0
6 7 2 0
6 8 1 0
8 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
5 14 1 0
9 14 2 0
2 8 1 0
15 16 1 0
15 17 2 0
15 18 1 0
11 18 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 248.24 | Molecular Weight (Monoisotopic): 248.0797 | AlogP: 1.16 | #Rotatable Bonds: 3 |
Polar Surface Area: 95.50 | Molecular Species: ACID | HBA: 3 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.87 | CX Basic pKa: ┄ | CX LogP: -0.02 | CX LogD: -3.25 |
Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.75 | Np Likeness Score: -0.43 |
References
1. Zaryanova EV, Lozinskaya NA, Beznos OV, Volkova MS, Chesnokova NB, Zefirov NS.. (2017) Oxindole-based intraocular pressure reducing agents., 27 (16): [PMID:28687205] [10.1016/j.bmcl.2017.06.065] |